Management of malignant phyllodes tumors of the breast: The experience of the Institut Curie;Prise en charge des tumeurs phyllodes malignes du sein : l'expérience de l'institut Curie

Cancer/Radiotherapie

Volumn 13, Issue 4, 2009, Pages 305-312

  Haberer, S ^a   Lae M ^a   Seegers, V ^a   Pierga, J Y ^a   Salmon, R ^a   Kirova, Y M ^a   Dendale, R ^a   Campana, F ^a   Reyal, F ^a   Miranda, O ^a   Fourquet, A ^a   Bollet, M A ^a  

^a INSTITUT CURIE   (France)

Author keywords

Breast cancer; Malignant phyllodes tumors; Radiotherapy

Indexed keywords

ANTHRACYCLINE; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; IFOSFAMIDE; VINCRISTINE SULFATE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL PRACTICE; CYSTOSARCOMA PHYLLOIDES; FOLLOW UP; HUMAN; MASTECTOMY; METASTASIS; PRIORITY JOURNAL; TUMOR VOLUME;

ADULT; BREAST NEOPLASMS; CANCER CARE FACILITIES; CHEMOTHERAPY, ADJUVANT; FEMALE; FRANCE; HUMANS; MASTECTOMY; MIDDLE AGED; PHYLLODES TUMOR; RETROSPECTIVE STUDIES; SURVIVAL RATE; YOUNG ADULT;

EID: 67649390737     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2009.05.001     Document Type: Article

References (37)

1. Abdalla H.M., and Sakr M.A. Predictive factors of local recurrence and survival following primary surgical treatment of phyllodes tumors of the breast. J Egypt Natl Canc Inst 18 (2006) 125-133
2. Barrio A.V., Clark B.D., Goldberg J.I., Hoque L.W., Bernik S.F., Flynn L.W., et al. Clinicopathologic features and long-term outcomes of 293 phyllodes tumors of the breast. Ann Surg Oncol 14 (2007) 2961-2970
3. Belkacémi Y., Bousquet G., Marsiglia H., Ray-Coquard I., Magné N., Malard Y., et al. Phyllodes tumor of the breast. Int J Radiat Oncol Biol Phys 70 (2008) 492-500 [centre Oscar-Lambret, Lille, France]
4. Belkacémi Y., Zouhair A., Ozsahin M., Azria D., and Mirimanoff R.-O. Facteurs pronostiques et prise en charge des tumeurs rares. Cancer Radiother 10 (2006) 323-329 [pour le réseau des cancers rares (Rare Cancer Network)]
5. Ben Hassouna J., Damak T., Gamoudi A., Chargui R., Khomsi F., Mahjoub S., et al. Phyllodes tumors of the breast: a case series of 106 patients. Am J Surg 192 (2006) 141-147
6. Bouhafa T., Masbah O., Bekkouch I., Afqir S., Mellas N., Ismaili N., et al. Phyllodes tumors of the breast: Analysis of 53 patients. Cancer Radiother (2008)
7. Chaney A.W., Pollack A., McNeese M.D., and Zagars G.K. Adjuvant radiotherapy for phyllodes tumor of the breast. Radiat Oncol Investig 6 (1998) 264-267
8. Chaney A.W., Pollack A., McNeese M.D., Zagars G.K., Pisters P.W., Pollock R.E., et al. Primary treatment of cystosarcoma phyllodes of the breast. Cancer 89 (2000) 1502
9. Cohn-Cedermark G., Rutqvist L.E., Rosendahl I., and Silfverswärd C. Prognostic factors in cystosarcoma phyllodes. A clinicopathologic study of 77 patients. Cancer 68 (1991) 2017-2022
10. Confavreux C., Lurkin A., Mitton N., Blondet R., Saba C., Ranchère D., et al. Sarcomas and malignant phyllodes tumours of the breast: a retrospective study. Eur J Cancer 42 (2006) 2715-2721
11. De Roos W.K., Kaye P., and Dent D.M. Factors leading to local recurrence or death after surgical resection of phyllodes tumours of the breast. Br J Surg 86 (1999) 396-399
12. Eich P.D., Diederich S., Eich H.T., Micke O., and Wagner W. Diagnostic radiation oncology: malignant cystosarcoma phylloides. Strahlenther Onkol 176 (2000) 192-195
13. Fou A., Schnabel F.R., Hamele-Bena D., Wei X.J., Cheng B., El Tamer M., et al. Long-term outcomes of malignant phyllodes tumors patients: an institutional experience. Am J Surg 192 (2006) 492-495
14. Foxcroft L.M., Evans E.B., and Porter A.J. Difficulties in the preoperative diagnosis of phyllodes tumours of the breast: a study of 84 cases. Breast 16 (2007) 27-37
15. Grimes M.M. Cystosarcoma phyllodes of the breast: histologic features, flow-cytometric analysis, and clinical correlations. Mod Pathol 5 (1992) 232-239
16. Hawkins R.E., Schofield J.B., Wiltshaw E., Fisher C., and McKinna J.A. Ifosfamide is an active drug for chemotherapy of metastatic cystosarcoma phyllodes. Cancer 69 (1992) 2271-2275 [Review]
17. Jee K.J., Gong G., Ahn S.H., Park J.M., and Knuutila S. Gain in 1q is a common abnormality in phyllodes tumours of the breast. Anal Cell Pathol 25 (2003) 89-93
18. Jones A.M., Mitter R., Springall R., Graham T., Winter E., Gillett C., et al. Phyllodes Tumour Consortium. A comprehensive genetic profile of phyllodes tumours of the breast detects important mutations, intratumoral genetic heterogeneity and new genetic changes on recurrence. J Pathol 214 (2008) 533-544
19. Kapiris I., Nasiri N., A'Hern R., Healy V., and Gui G.P. Outcome and predictive factors of local recurrence and distant metastases following primary surgical treatment of high-grade malignant phyllodes tumours of the breast. Eur J Surg Oncol 27 (2001) 723-730
20. Laé M., Vincent-Salomon A., Savignoni A., Huon I., Fréneaux P., Sigal-Zafrani B., et al. Phyllodes tumors of the breast segregate in two groups according to genetic criteria. Mod Pathol 20 (2007) 435-444
21. Lenhard M.S., Kahlert S., Himsl I., Ditsch N., Untch M., and Bauerfeind I. Phyllodes tumour of the breast: clinical follow-up of 33 cases of this rare disease. Eur J Obstet Gynecol Reprod Biol 138 (2008) 217-221
22. Lv S., Niu Y., Wei L., Liu Q., Wang X., and Chen Y. Chromosomal aberrations and genetic relations in benign, borderline and malignant phyllodes tumors of the breast: a comparative genomic hybridization study. Breast Cancer Res Treat (2008)
23. Macdonald O.K., Lee C.M., Tward J.D., Chappel C.D., and Gaffney D.K. Malignant phyllodes tumor of the female breast: association of primary therapy with cause-specific survival from the Surveillance, Epidemiology, and End-Results (SEER) program. Cancer 107 (2006) 2127-2133
24. Morales-Vásquez F., Gonzalez-Angulo A.M., Broglio K., Lopez-Basave H.N., Gallardo D., Hortobagyi G.N., et al. Adjuvant chemotherapy with doxorubicin and dacarbazine has no effect in recurrence-free survival of malignant phyllodes tumors of the breast. Breast J 13 (2007) 551-556
25. Pezner R.D., Schultheiss T.E., and Paz I.B. Malignant phyllodes tumor of the breast: local control rates with surgery alone. Int J Radiat Oncol Biol Phys 71 (2008) 710-713
26. Reinfuss M., Mituś J., Duda K., Stelmach A., Ryś J., and Smolak K. The treatment and prognosis of patients with phyllodes tumor of the breast: an analysis of 170 cases. Cancer (1996) 77910-77916
27. Riepl M., and Strnad V. Radiochemotherapy in the liver metastases of cystosarcoma phyllodes. Strahlenther Onkol 170 (1994) 668-672
28. Roa J.C., Tapia O., Carrasco P., Contreras E., Araya J.C., Muñoz S., et al. Prognostic factors of phyllodes tumor of the breast. Pathol Int 56 (2006) 309-314
29. Rowell M.D., Perry R.R., Hsiu J.G., and Barranco S.C. Phyllodes tumors. Am J Surg 165 (1993) 376-379
30. Stockdale A.D., and Leader M. Phyllodes tumour of the breast: response to radiotherapy. Clin Radiol 38 (1987) 287
31. Taira N., Takabatake D., Aogi K., Ohsumi S., Takashima S., Nishimura R., et al. Phyllodes tumor of the breast: stromal overgrowth and histological classification are useful prognosis-predictive factors for local recurrence in patients with a positive surgical margin. Jpn J Clin Oncol 37 (2007) 730-736
32. Tan P.H., Jayabaskar T., Chuah K.L., Lee H.Y., Tan Y., Hilmy M., et al. Phyllodes tumors of the breast: the role of pathologic parameters. Am J Clin Pathol 123 (2005) 529-540
33. In: Tavassoli F.A., and Devilee P. (Eds). World Health Organization Classification of Tumors. Pathology and genetics of tumors of the breast and female genital organs (2003), International Agency for research on Cancer Press, Lyon 99-103
34. Telli M.L., Horst K.C., Guardino A.E., Dirbas F.M., and Carlson R.W. Phyllodes tumors of the breast: natural history, diagnosis, and treatment. J Natl Compr Canc Netw 5 (2007) 324-330
35. Tse G.M., Lui P.C., Scolyer R.A., Putti T.C., Kung F.Y., Law B.K., et al. Tumour angiogenesis and p53 protein expression in mammary phyllodes tumors. Mod Pathol 16 (2003) 1007-1013
36. Tse G.M., Lui P.C., Vong J.S., Lau K.M., Putti T.C., Karim R., et al. Increased epidermal growth factor receptor (EGFR) expression in malignant mammary phyllodes tumors. Breast Cancer Res Treat (2008)
37. Vladescu T., Klijanienko J., Caillaud J.M., Lagacé R., and Vielh P. Fine-needle sampling in malignant phyllodes tumors: clinicopathologic study of 22 cases seen at the Institut Curie. Diagn Cytopathol 31 (2004) 71-76